ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 52-Week Low at $14.60

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares traded. The stock had previously closed at $15.09. Analysts Set New Price Targets Several brokerages have […]

Related Keywords

Canada ,United States ,America ,James Kihara ,Markc Schneyer ,Jpmorgan Chase Co ,Shell Asset Management Co ,Covestor Ltd ,Headlands Technologies ,Citigroup ,Quest Partners ,Pharmaceuticals Daily ,Nasdaq ,Pharmaceuticals Inc ,Pharmaceuticals Price Performance ,Royal Bank ,Acadia Pharmaceuticals Inc ,Get Free Report ,Management Fondsmaeglerselskab ,Shell Asset Management ,Asset Management ,